Hemogenyx Pharmaceuticals
Ronen Ben Jehuda, PhD has a background in Biotechnology Engineering, earning a Bachelor of Science degree from Technion - Israel Institute of Technology. Ronen later went on to complete a Master of Science in Biotechnology and a Doctor of Philosophy in Stem cells and electrophysiology of cardiac muscle at the same institute. Ronen has gathered experience in various roles, including as a Researcher at Technion, a Research Assistant Professor at SUNY Downstate Medical Center, and currently holds the position of Principal Scientist at HemoGenyx Pharmaceuticals Ltd. Ronen has also been involved in drug screening projects at Servier, focusing on antiarrhythmic drugs for Catecholaminergic Polymorphic Ventricular Tachycardia.
This person is not in any offices
Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.